Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHEA for IVF Poor Responders
NCT04066478Phase 3Suspended
- Sponsor
- Homerton University Hospital
- Start
- Oct 2017
- Primary completion
- Dec 2022
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 3 trial of dehydroepiandrosterone in female infertility, sponsored by Homerton University Hospital. Started Oct 2017; status: suspended.
02
Drugs
dehydroepiandrosterone
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT04066478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04066478.